Case Report: What Are We Doing for Our "20/20 Unhappy" Scleral Lens Patients?


Journal

Optometry and vision science : official publication of the American Academy of Optometry
ISSN: 1538-9235
Titre abrégé: Optom Vis Sci
Pays: United States
ID NLM: 8904931

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 18 9 2020
medline: 17 4 2021
entrez: 17 9 2020
Statut: ppublish

Résumé

Scleral lenses (SLs) partially mask higher-order aberrations (HOAs) in highly aberrated eyes. Although visual acuity (VA) may show satisfactory quantitative clinical outcomes during SL wear, residual (uncorrected) HOAs can leave subjective visual quality goals unmet. The purpose of this study was to report a case where a "20/20 unhappy" patient with SLs was able to meet visual goals with wavefront-guided SLs. A 40-year-old male with bilateral keratoconus, whose Snellen VA with SLs was 20/20 right eye (OD) 20/16 left eye (OS), reported halos and glare at night and perceptual smearing. When viewing a point of light, a "Ferris wheel" shadowing was observed OD and a U-shaped shadowing OS. Residual higher-order root mean square wavefront error was 0.49 μm OD and 0.39 μm OS; visual image quality measured by visual Strehl ratio was 0.067 OD and 0.092 OS (pupil size, 4.00 mm). Wavefront-guided SLs reduced residual higher-order root mean square to 0.19 μm OD and 0.25 μm OS, VA improved to 20/10 OD and 20/13 OS, and visual Strehl improved to 0.150 OD and 0.121 OS. The patient reported reduced smearing, shadowing, and night vision concerns, meeting his visual expectations and goals. Wavefront sensing quantifies both lower and HOAs, which can cause visual dissatisfaction in individuals with highly aberrated eyes, despite sometimes reaching typical levels of VA. As wavefront-guided SLs targeting these residual aberrations to improve visual image quality become more available, they should be considered for 20/20 unhappy patients when conventional clinical options are unsatisfactory.

Identifiants

pubmed: 32941339
doi: 10.1097/OPX.0000000000001563
pmc: PMC7530009
mid: NIHMS1618037
pii: 00006324-202009000-00024
doi:

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

826-830

Subventions

Organisme : NEI NIH HHS
ID : P30 EY007551
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY019105
Pays : United States

Références

Optom Vis Sci. 2019 Apr;96(4):238-247
pubmed: 30943184
Am J Ophthalmol. 2017 Mar;175:169-172
pubmed: 28039037
Cornea. 2018 Mar;37(3):400-404
pubmed: 29215397
J Opt Soc Am A Opt Image Sci Vis. 2001 Aug;18(8):1793-803
pubmed: 11488483
J Opt Soc Am A Opt Image Sci Vis. 2007 Mar;24(3):578-87
pubmed: 17301847
Clin Exp Ophthalmol. 2009 Jan;37(1):118-29
pubmed: 19338609
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3062-8
pubmed: 17591874
Optom Vis Sci. 2013 Apr;90(4):314-23
pubmed: 23478630
Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2537-46
pubmed: 9856763
J Opt Soc Am A Opt Image Sci Vis. 2018 May 1;35(5):732-739
pubmed: 29726489
Optom Vis Sci. 2014 Oct;91(10):1221-30
pubmed: 24830371
J Cataract Refract Surg. 2012 Sep;38(9):1671-83
pubmed: 22906449
Int Ophthalmol Clin. 2016 Spring;56(2):19-45
pubmed: 26938336
J Cataract Refract Surg. 2011 Aug;37(8):1523-9
pubmed: 21782097

Auteurs

Lan Chi Nguyen (LC)

Visual Optics Institute, College of Optometry, University of Houston, Houston, Texas.

Matthew J Kauffman (MJ)

Visual Optics Institute, College of Optometry, University of Houston, Houston, Texas.

Raymond A Applegate (RA)

Visual Optics Institute, College of Optometry, University of Houston, Houston, Texas.

Jason D Marsack (JD)

Visual Optics Institute, College of Optometry, University of Houston, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH